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The gastric factors controlling abundance of mRNA encoding the important neuropeplide, gastrin releasing peptide (GRP) in rat stomach, were 
examined by Northern and SIOI blot analysis. Withdrawal of food increased antral GRP mRNA, asdid treatment offed rats with theacid inhibitory 
drug, omeprazole. There was no change in GRP mRNA abundance in !&stric corpus. The data indicate functionally distinct populations of GRP 
neurons in different regions of lhc slomach, and control of antral ncuropcptidc biosynthesis by the gastric luminal contents. 
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1. INTRODUCTION 
The processes of gastric digestion are regulated by 
enteric neurons and gut hormones [I]. Gastrin releasing 
peptide (GRP), is one of the best studied neuropeptides 
cf the gut: it plays a well recognised role in the control 
of gastric function as the main neurotransmitter govern- 
ing release of the important acid-regulatory substances, 
gastrin and somatostatin [2]. It also has mitogenic ef- 
fects in vitro and is a potential autocrine growth factor 
in some tumours [3]. It is now clear that the luminal 
contents of the stomach, particularly food and acid, 
modulate the abundance of mRNA species encoding 
gasrrin and somatostatin which are found in epithelial 
endocrine cells [4-71. It is not clear, however, whether 
the luminal contents of the gut are also able to influence 
synthesis of peptides in cnteric neurons. In view of the 
well-defined physiology of GRP, this peptide provides 
a good model for examination of this issue. We report 
here that in a subpopulation of gastric GRP neurons, 
mRNA abundance is determined by food and acid in 
the gastric lumen. 
H./K’ ATPasc inhibitor, omcprazolc, have previously been described 
[7.8]. In brief, fasted tills were housed on wire-bottomed cages without 
access to food, but with water ad libitum for 48 h. Omcpmzole was 
given in a dose of 400pB/kg, p.0,. in 0.25% methyl cellulose, daily. At 
the end of the experimental period rats were killed and the antral and 
corpus regions of the stomach separately removed for extraction of 
RNA. 
Complemenlaty cDNA probes were simultaneously synthesized 
and radiolabelled by PCR. and purified on Qiagen Tip5 minicolumns 
as previously described [7.8]. Primers for PCR were synthesized on an 
Applied Biosystems 391 oligonucleotide synthesizer and corresponded 
to bases -46 to -26 (sense) and bases 627 to 636(nntisense) of rat GRP 
cDNA [9]: rat brain cDNA was used as template. Oligo (dT)% was 
synthesized and end&belled with polynucleotidc kinase according to 
standard methods. The identity of PCR-generated probes was con- 
firmLvi by restriction endonucleasc digestion and agarose gel electron 
phoresis (Fig. I). 
2.3. Pwpururion orrd unul.vsis of rrrRNA 
2. MATERIALS AND METHODS 
?.I. Anirnuls urrd frPull?fh~~lS 
Studies were made on remtile Wistar rats of approximately 250 g, 
kept on a 12-h light/dark cycle. The protocols used to examine lhe 
influence of rood withdrawal, or of inhibition of gastric acid by the 
Total RNA was extracted as previously described [7,8]. Preliminary 
experiments with Northern blots indicated low message abundance, 
and subsequent s udies were made on mRNA purified on Hybond 
mAP paper (Amersham) according to the manufacturers instructions. 
Northern blots were performed as previously described [7,8]. Slot blots 
were made onto nylon membranes (Hybond N. Amersharn) according 
to the manufacturers protocol, using a Bio-slot manifold (Bio rad). 
Slot blots were hybridized first with a 672 base pair (bp) PCR-gencr- 
ated cDNA probe for GRP, washed and exposed to Kodak X-AR film 
according to previously published protocols f7j, The probe was 
stripped with boiling0. I% SDS, and the membranes rehybridized with 
a 362 bp PCR-generated cDNA prohe for rat gastrin Iq, and finally 
rchybridized with end-lab&d oligo (dT)%, to ascertain equal oading. 
Blots were quantified by video dcnsitometry. 
Vrescr~r ud~rcss: Department of Medicine. University Hospital, 
Trondheim, Norway. 3. RESULTS AND DISCUSSION 
Crrrrcs~or~rlcr~cc o&irexs: G.J. Dockray, Department of Physiology, 
University of Liverpool, PO Hex 147, Liverpool L69 3BX, UK. Fax: 
(44) (51) 794 5327. 
Gastric GRP mRNA was present only in low abun- 
dance, and ir, Northern b!ors of total RNA was scarcely 
detectable. ihis is not particularly surprising given that 
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Fig. 1, Restriction analysis of GRP EDNA probe. GRP cDNA was 
synthesized by PCR as described in Section 2. PCR product (antici- 
pated size 672 bp) was purified by phenol/chloroform extraction, eth- 
anol precipitated and digested with restriction cndocnuclease. The 
products were elcctrophorcscd in 1.5% agarose gels. Lane I, Prnll 
digest, anticipated products 244,216 and 129 bp, Lane 2, Ml digest, 
anticipated products, 445 and 227 bp. Lane 3, &RI digest, anti& 
patcd size 672 bp. Arrows indicate positions of DNA size markers, 
Note predicted products in each case. 
the gene is expressed in a minority of cells of the myen- 
teric plexus, which is itself a very small proportion of 
total tissue. In Northern blots of gastric mRNA there 
was a single GRP species of approximately 1 kb, which 
corresponds to the mRNA previously reported in rat 
(colon/duodenum) and predicted from the reported 
cDNA sequence. In brain, an additional 1.5 kb tran- 
script has been described, derived from an alternative 
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Fig. 2. Relationship between mRNA loaded and signal obtained in 
Northern blots. Gastric corpus total and mRNA samples were prc- 
pared 3s described inSection 2, elcctrophorcscd in I% agarose/formal- 
dehydc gels and transfcrrcd to nylon membranes. Membranes were 
hybridized with GRP cDNA probe and quantified by video densitom- 
otrf. Lane I, 20~~ total Rh’A. Lanes 2-6 eontairr g, 4, 2, I anclO.5 
yg mRNA. Size markers 3re ribosomal subunits. A linear relationship 
bctwccn mRNA loaded and signal was also obtained in slot blots (not 
ANTRUM 
Fig. 4. Gastrin und GRP mRNA abundance in antrum and corpus of 
fasted and fed tats. trcatcd with omcprazolc or vehicle. Values are 
expressed as percent of antral mRNA levels in fed rats (/z=5). No 
gastrin signal was dcucted in any corpus mRNA sample, In all three 
treatment groups, antral GRP mRNA abundance was signilicantly 
clcvated compared with control animals fed ad libitum (kO.05, 
shown). ANOVA). 
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Fig. 3. Slot blot analysis of antral and corpus mRNA from fasted and 
fed rats treated with omcprazole or vehicle. Membranes were hybrid- 
ized scqucntially with GRP and gastrin cDNA probes, then oligo 
(dT& Gastrin and GRP signa;isy;re normalized to the oligo (dT) 
transcription start site [9]: no evidence of the latter form 
was found in stomach, either in control tissue or after 
the various treatments described below, indicating that 
the alternative start site is not employed in this tissue. 
There was a linear relationship between signal strength 
and mRNA loaded, indicating that Northern and slot 
blots could be used for quantification of GRP mRNA 
(Fig. 2). 
Inhibition of acid secretion with omeprazole in rats 
fed ad libitum produced a striking 3-fold increase in 
GRP mRNA in the antral region of the stomach; ome- 
prazole also increased antral GRP mRNA abundance 
in rats that were fasted for 48 h. It is well established 
that in these circumstances there is an increase in gastrin 
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mRNA [4,5,7], and rehybridization of the membranes 
with a gastrin probe confirmed the expected increases 
(Figs. 3 and 4). However, parallel changes in gastrin and 
GRP mRNAs were not observed after withdrawal of 
food for 48 h. In this case there was a three-fold increase 
in antral GRP mRNA, but as expected from previous 
work [6,7] there was a marked fall in gastrin mRNA. It 
is of interest hat antral somatostatin mRNA abun- 
dance increases with food withdrawal, so that changes 
in GRP mRNA abundance share features in common 
with both control of somatostatin and gastrin mRNAs. 
Whether or not the changes in GRP mRNA abundance 
reflect the response of a single population of neurons 
remains to be determined. In this context it is important 
to note, however, that the abundance of GRP mRNA 
in the acid secreting part of the stomach was not 
changed by omeprazole or food withdrawal (Figs. 3 and 
4). These observations provide prima facie evidence for 
distinct sub-populations of GRP neurons in the two 
functionally distinct regions of the stomach; moreover, 
they suggest that the changes in antral GRP mRNA are 
not non-specific in nature. 
The pcptidergic neurons of the gut have been impli- 
cated in control of all major aspects of gastrointestinal 
function including motility, secretion and blood flow 
[lo]. Genes encoding the major neuropeptides have 
been cloned and sequenced but functional control of 
peptide production, reflected for example in mRNA 
abundance, have remained largely unexplored, perhaps 
in part because mRNA abundance is low. Because GRP 
has well recognized physiological actions in the stom- 
ach, it is a good model for study of this issue. The 
present data show that mRNA levels for GRP are mod- 
ulated by luminal contents of the stomach indicating 
that changes in neuropeptide production depend on 
food intake. This in turn indicates that altered patterns 
of turnover of neuropeptide at nerve terminals, in this 
case controlling gastrin and somatostatin, are likely to 
be important in adapting gastric mucosal function to 
changing patterns of luminal stimulation. 
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